Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor cell plasma membrane is the outer lipid bilayer of a cancer cell, containing unique protein and lipid compositions that regulate the entry and exit of molecules, influence drug resistance, and are involved in cell signaling, interaction with the tumor microenvironment, and metastasis[2][3]. The mitochondrial membrane is essential for maintaining mitochondrial function and is involved in the regulation of apoptosis; its permeabilization is a critical event in programmed cell death and is a focus in some anti-cancer strategies[3]. Both membranes differ from those in normal cells in lipid composition, degree of saturation, cholesterol content, and signaling platform organization, making them attractive but non-specific targets for novel cancer therapies[2][3][4].
Modulating membrane fluidity/composition to enhance drug uptake or trigger apoptosis; Clustering or targeting death receptor pathways via membrane lipid modulation; Disruption of membrane integrity or mitochondrial outer membrane permeabilization
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell plasma membranes and mitochondrial membranes.